Insider Transactions Reported by 17 Insiders of PDS Biotechnology Corp

Symbol
PDSB on Nasdaq
Location
Princeton, NJ

Insiders trading volume in the past year

PDS Biotechnology Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
DeLyle W. Bloomquist Resigned as a Director on June 17, 2021. $7,813,350 16 Jun 2021
SETH VAN VOORHEES Chief Financial Officer $172,588 15 Jun 2021
Stephen C. Glover Director $130,893 +$25,001 +24% 11 Jun 2025
Gregory Freitag Director $101,614 +$25,000 +33% 11 Jun 2025
GREGORY CONN Chief Scientific Officer 28 Feb 2024
LAUREN WOOD Chief Medical Officer 05 Jan 2023
Spencer Brown Senior VP, General Counsel 28 Feb 2024
OTIS W. BRAWLEY Director 11 Jun 2025
Ilian Iliev Director 11 Jun 2025
RICHARD SYKES Director 24 Jun 2024
Lars Boesgaard Chief Financial Officer 12 Jun 2025
FRANK BEDU-ADDO President/CEO, Director 28 Feb 2024
Kirk V. Shepard Chief Medical Officer 12 Jun 2025
Janetta Trochimiuk Principal Accounting Officer 30 Sep 2021
Stephan Toutain Chief Operations Officer 12 Jun 2025
Kamil Ali-Jackson Director 11 Jun 2025
MATTHEW C. HILL Chief Financial Officer 05 Jan 2023

Recent Insider Transactions by Companies or Individuals for PDS Biotechnology Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.